KPKarina A. Pogosian

Karina A. Pogosian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karina A. Pogosian has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vitamin D: a history spanning over a century

    by T. L. Karonova, K. A. Golovatiuk, O. M. Lesnyak, E. V. Kovalenko, A. T. Chernikova, K. A. Pogosyan, A. A. Nikulina, E. A. Pigarova

    Vitamin D is one of the most extensively studied nutrients, playing a key role in maintaining human health. The history of its research spans over 100 years, encompassing stages from the description of rickets and osteomalacia to the deciphering of molecular mechanisms of action and the recognition of its pleiotropic effects. Despite a significant body of accumulated data, debates persist to this day regarding optimal target levels of 25(OH)D, indications for prescribing vitamin D supplements, and the clinical significance of its extraskeletal effects. This review sequentially examines the main historical milestones in the discovery of vitamin D, the contributions of foreign and Russian scientists, modern concepts of its biochemistry and metabolism, and its role in regulating bone, metabolic, endocrine, immune, cardiovascular, and nervous system homeostasis. Special attention is given to the problem of the high prevalence of vitamin D deficiency in the Russian Federation, caused by geographical, climatic, and dietary factors. The article summarizes current international and Russian clinical guidelines, discusses approaches to the prevention and correction of vitamin D deficiency, and outlines promising directions for future research.

  • Open Access

    Modern possibilities of the diagnosing of primary hyperparathyroidism

    by Marina E. Boriskova, Polina A. Pankova, Lina A. Khamid, Mikhail A. Bykov, Daria V. Zuykevich, Kristina V. Valiakhmedova, Zalina M. Ulimbasheva, Karina A. Pogosy0An, Tatiana L. Karonova, Daria V. Ryzhkova

    Background. Currently, the most common method of preoperative imaging of affected parathyroid glands (PTG) is a combination of scintigraphy with technetium [99mTc] sestamibi and neck ultrasound (with a sensitivity of 81–95%). In some cases, such as multiple PTG lesions, their ectopic location, multiple nodular thyroid lesions, and their hyperfunction or inflammation, standard imaging methods may show negative or contradictory results, which requires the use of 2nd-line diagnostic studies. One is positron emission tomography combined with computed tomography (PET/CT) with 11C-choline. Aim. To determine the role of PET/CT with 11C-choline in the topical diagnosis of primary hyperparathyroidism. Materials and methods. Retrospective analysis of data from 33 patients with primary hyperparathyroidism who underwent parathyroidectomy at the Department of Surgical Endocrinology of Pavlov First Saint Petersburg State Medical University from 2022 to 2024. Due to the ineffectiveness of standard imaging and/or the persistence of primary hyperparathyroidism after the first surgery, all patients included in the study underwent PET/CT with 11C-choline (Almazov National Medical Research Centre). The accuracy, sensitivity, specificity, and positive and negative predictive values were calculated considering the pathological postoperative verification of adenoma/hyperplasia and/or achievement of the reference range of parathyroid hormone and calcium plasma levels. Results. A total of 41 masses were removed in 33 patients (8 patients had 2 masses removed each). Thirty-seven areas were positive according to PET/CT with 11C-choline. Its diagnostic accuracy was 95.5%, sensitivity 90.2%, specificity 97.8%, positive predictive value 94.9%, and negative predictive value 95.7%. Conclusion. PET/CT with 11C-choline demonstrated high efficacy in preoperative localization assessment of PTG adenomas, even in cases where the results of first-line imaging methods were ambiguous. We use this method in complex cases, although it can be considered an alternative to first-line imaging. This question remains open and requires further studies comparing economic feasibility.

  • Open Access

    Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia

    by Uliana Tsoy, Karina Pogosian, Daria Ryzhkova, Olga Yudina, Ksenia Yakovenko, Pavel Ryazanov, Irina Matsueva, Polina Sokolnikova, Maksim Salov, Tatiana Karonova, et al.

    Background: Parathyroid tumors are classified as parathyroid neuroendocrine neoplasia (NEN) by the IARC-WHO classification. These tumors can occur with NENs from other sites, which often require total-body [68Ga]-DOTA-peptides PET/CT. This study aimed to assess the utility of [68Ga]-DOTA-peptide PET/CT in imaging parathyroid NENs and to evaluate the underlying mechanisms. Methods: Fifty patients with primary hyperparathyroidism (PHPT) and parathyroid NENs histologically confirmed as parathyroid adenomas (PAs) were included. PET/CT with [68Ga]-DOTA-peptide was performed in 16 patients with localized PAs, including 10 with MEN1 syndrome. Somatostatin receptor types 2 and 5 (SST2 and SST5) staining was performed on PAs from 48 patients. Somatostatin analogs (SSA) were prescribed in four patients with MEN 1 syndrome and 1 with persistent acromegaly, all with PAs and PHPT. The therapy effects on calcium and parathyroid hormone (iPTH) were evaluated. Results: [68Ga]-DOTA-peptide PET/CT detected 20 PAs with high radiopharmaceutical uptake. SST2 expression was negative on PA cell membranes in all cases and positive on endothelium in 39 (81%) PAs. Membrane SST5 expression was positive in 25 (52%) PAs and endothelial was positive in 40 (83%). Serum calcium levels decreased in patients on SSA therapy, while iPTH did not. Conclusions: PET/CT with [68Ga]-DOTA-peptides can detect parathyroid NENs. The incidental detection of high [68Ga]-DOTA-peptide uptake in the parathyroid region during whole-body PET/CT may prompt biochemical evaluation for PHPT. We suggest that endothelial SST expression mediates high radiopharmaceutical uptake by PAs and that SSA treatment can reduce hypercalcemia in PHPT patients.


  • Open Access

    Preoperative visualization of parathyroid pathology in patients with primary hyperparathyroidism using PAT/KT: a retrospective study

    by V. A. Pospelov, K. A. Pogosyan, O. V. Yudina, R. V. Kirillov, Kh. Kh. Dоvletmerzaeva, E. V. Ivanikha, M. A. Salov, T. L. Karonova, D. V. Ryzhkova, Х. Х. Довлетмерзаева

    INTRODUCTION: Topical diagnosis of pathologically altered parathyroid glands in patients with primary hyperparathyroidism is a challenge both for specialists of radial diagnostics and for planning the scope of surgical intervention. The choice of diagnostic modality for localization of parathyroid glands depends on the availability of the method for a particular medical center. PET/CT is a promising method to determine the localization of parathyroid adenomaOBJECTIVE: To analyze the experience of using PET/CT with 11C-methionine and PET/CT with 11C-choline for preoperative diagnosis of parathyroid pathology in patients with primary hyperparathyroidism.MATERIALS AND METHODS: 72 patients diagnosed with PHPT and underwent surgical treatment were included in the study. Before surgical intervention all patients underwent laboratory and instrumental investigations in the scope of: blood tests for PTH, TTH, ionized calcium, calcitonin, 25(OH)D, creatinine, phosphorus, ultrasound of the neck, computer tomography of the neck with intravenous bolus contrasting.RESULTS: PET/CT showed the highest rates of DA in the patient group before primary surgery — 90.9%, compared with ultrasound (89.6%) and CT with IV contrast (84.9%). In the group of solitary adenomas of ectopic MTCS, PET/CT also had a higher DA — 92.8% than the other modalities. In patients with relapsed or persistent disease, the informativity rates of CT with intravenous contrast and PET/CT were similar (Se — 100%, Sp — 94.1%, DT — 96.2%).DISCUSSION: The algorithm for preoperative evaluation of patients to identify the location of pathologic parathyroid glands now includes imaging with two modalities: Neck ultrasound and radionuclide imaging: planar scintigraphy (washout/subtraction), SPECT, SPECT-CT. If the results are questionable, a CT scan of the neck with contrast or PET/CT is performed as a second step. None of the modalities has 100% diagnostic accuracy. Our study demonstrated the superiority of PET/CT over ultrasound and CT w/in contrast in a group of patients scheduled for primary surgical treatment. In a small group of patients, high informative rates of PET/CT and CT with contrast were demonstrated before reoperation, confirming the great potential of these techniques in these patients.CONCLUSION: PET/CT with 11C-methionine and PET/CT with 11C-choline have high diagnostic accuracy in patients with primary hyperparathyroidism before reoperation. PET/CT and CT with contrast showed similarly high diagnostic accuracy for the diagnosis of parathyroid adenoma with persistence or recurrence of the disease in patients with primary hyperparathyroidism.


  • Open Access

    Comparision of 11C-methionine and 11C-choline pet/ct for parathyroid visualization: a prospective study

    by K. А. Pogosian, T. L. Karonova, D. V. Ryzhkova, L. G. Yanevskaya, M. E. Boriskova, D. V. Zuykevich, O. V. Yudina, U. A. Tsoy, E. N. Grineva

    INTRODUCTION: Primary hyperparathyroidism (PHPT) is a common endocrine disorder. Minimal invasive parathyroidectomy (PTX) is favorable surgical approach in PHPT treatment. Its success is highly dependent on accurate preoperative localization of all causative parathyroid adenomas. Despite the fact that wide range of visualization methods are applied in PHPT diagnostics, PHPT persistence occurs. Therefore, the search for additional visualizing tools of parathyroid adenomas remains relevant. Recently, positron emission tomography/computed tomography (PET/CT) has been used in order to improve PHPT diagnostics. OBJECTIVE: To evaluate the diagnostic effectiveness of PET/CT with 11C-methionine and 11C-choline in patients with PHPT based on the intensity of both tracers uptake in parathyroid adenomas. MATERIALS AND METHODS: The data of 26 patients diagnosed with PHPT was analyzed. PET/CT with 11C-choline was performed in 14 patients, with 11C-methionine — in 10 patients, with two radiopharmaceuticals — in two patients. All patients underwent PTX. Histological examination’s results were compared with the results of PET/CT. Using the software, the standardized uptake value of radiopharmaceuticals in histologically verified parathyroid adenomas/hyperplasias and in the trapezius muscle was obtained, then tumor-to-background ratios (TBR) of 11C-methionine and 11C-choline were calculated.Statistics: Software STATISTICA 10 was used in statistical analysis.RESULTS: 11C-choline TBR median was of 2.3 (1.6; 3.2), median of 11C-methionine TBR showed slightly higher values — 2.5 (1.9; 3,6). However, no significant difference was found between the two radiopharmaceuticals’ uptake in parathyroid adenomas.DISCUSSION: The scientific impact of current study is determined by the diagnostic effectiveness comparison between PET/CT with 11C-methionine and 11C-choline, which is based on the accumulation intensity of both radiopharmaceuticals in parathyroid adenomas.CONCLUSION: The intensity of accumulation of 11C-methionine and 11C-choline by hyperfunctioning parathyroid tissue does not differ significantly. Thus both tracers might be successfully applied for topic diagnosis of parathyroid adenomas in patients with PHPT.


  • Open Access

    11С-methionine PET/CT use in the diagnosis of primary hyperparathyroisis

    by K. A. Pogosian, T. L. Karonova, D. V. Ryzhkova, U. A. Tsoy, A. N. Semenova, O. V. Yudina, E. N. Grineva

    Актуальность. Первичный гиперпаратиреоз (ПГПТ) — эндокринное заболевание, характеризующееся автономной секрецией паратиреоидного гормона (ПТГ). Радикальным методом лечения ПГПТ является паратиреоидэктомия (ПТЭ), результат которой в большой степени зависит от точной визуализации аденомы околощитовидных желез (ОЩЖ) на предоперационном этапе. К традиционным методам топической диагностики ПГПТ относятся ультразвуковое исследование (УЗИ), сцинтиграфия, мультиспиральная компьютерная томография (МСКТ), каждый из них имеет свои ограничения. С целью улучшения диагностики применяют позитронно-эмиссионную томографию/компьютерную томографию (ПЭТ/КТ) с 11C-метионином. Цель. Сравнить чувствительность и специфичность ПЭТ/КТ с 11С-метионином с аналогичными характеристиками традиционных методов визуализации аденом околощитовидных желез. Материалы и методы. Были проанализированы данные 91 больного с диагнозом ПГПТ. УЗИ, сцинтиграфия с 99mTc-сестамиби/99mTc-пертехнетатом и МСКТ были выполнены 91, 56 и 86 пациентам соответственно. С 2020 года ПЭТ/КТ с 11C-метионином использовалась в качестве завершающего метода топической диагностики у 45 больных. Оценка диагностических характеристик визуализирующих методов проводилась на основании результатов гистологического исследования. Результаты. Гистологическое исследование подтвердило наличие аденомы/гиперплазии ОЩЖ у всех больных. Множественные аденомы/гиперплазии были обнаружены в 5 случаях. Эктопированные аденомы были выявлены у 19 больных. Чувствительность ПЭТ/КТ с 11C-метионином составила 98 %, МСКТ, сцинтиграфии и УЗИ — 75 %, 79 %, 67 % соответственно. Специфичность — 93 %, 73 %, 75 %, 70 % соответственно. Заключение. ПЭТ/КТ с 11C-метионином продемонстрировала более высокие показатели чувствительности и специфичности, чем традиционные методы визуализации аденом ОЩЖ.


  • Open Access

    Role of 11C-choline PET/CT in parathyroid adenomas’ localization in patients with primary hyperparathyroidism

    by K. A. Pogosian, T. L. Karonova, D. V. Ryzhkova, L. G. Yanevskaya, U. A. Tsoy, O. V. Yudina, E. V. Ivanikha, E. N. Grineva

    Background. Topical diagnosis of primary hyperparathyroidism (PHPT) remains an urgent problem due to the high incidence of persistence and recurrence after surgical treatment. At the preoperative stage, a search for the parathyroid hormone hyperproduction source is performed using instrumental methods: ultrasound, scintigraphy of the parathyroid glands (PTG) and multislice computed tomography (MSCT). The cause of PHPT persistence and recurrence after parathyroidectomy may be the multiple nature of PTG lesions or their ectopic location. Additional methods of visualization of PTG adenomas can be used to improve diagnosis (PET/CT).Objective. To compare the sensitivity and specificity of PET/CT with 11C-choline with the traditional visualization techniques.Design and methods. 16 PHPT patients were analyzed. All patients underwent US, subtraction scintigraphy with 99mTc-technetril/99mTc-pertechnitate and CT were performed in 12 and 16 patients, respectively. 11C-choline PET/CT was used for all patients. Imaging results’ coincidence of two methods were labeled as the true one.Results. The sensitivity of PET/CT with 11C-choline was 94 %, CT, subtraction scintigraphy with 99mTc-technetril/99mTc-pertechnitate and US — 75 %, 69 % and 63 %, respectively. The specificity of PET/CT with 11C-choline, CT, scintigraphy with 99mTc-technetril/99mTc-pertechnitate, and US was 100 %, 84 %, 76 %, and 68 %, respectively.Conclusion. PET/CT with 11C-choline demonstrated best sensitivity and specificity among all methods and can become an alternative in PHPT diagnostics in case of negative or inconvclusive results of previous visualization.


  • Open Access

    11C-methionine PET/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism

    by Karina Pogosian, Tatiana Karonova, Daria Ryzhkova, Liubov Yanevskaya, Uliana Tsoy, Olga Yudina, Gleb Berkovich, Anna Dalmatova, Elena Grineva

    Original Article 11C-methionine PET/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism Karina Pogosian, Tatiana Karonova, Daria Ryzhkova, Liubov Yanevskaya, Uliana Tsoy, Olga Yudina, Gleb Berkovich, Anna Dalmatova, Elena Grineva


  • Open Access

    Hungry bone syndrome in delay diagnosed primary hyperparathyroidism with fi brocystic osteitis: A case report

    by K. A. Pogosian, L. G. Yanevskaya, A. N. Semenova, M. A. Molotkova, G. V. Berkovich, D. V. Ryzhkova, L. V. Belousova, U. A. Tsoi

    Fibrocystic osteitis is a rare but severe primary hyperparathyroidism (PHPT) complication. We describe a 66-year-old female presented with fi brocystic osteitis and nephrocalcinosis with eGFR reduction to CKD stage 4 due to primary hyperparathyroidism. Delayed diagnosis of long-term hypercalcemia, high parathyroid hormone level, unsubstituted 25(OH)D defi ciency, and the use of bisphosphonates in high doses caused development of «hungry bones» syndrome in early postoperative period. Severe hypocalcemia required prescription of active and native vitamin D metabolites, oral calcium supplements as well as intravenous calcium. Delay in diagnosis of PHPT with fi brocystic osteitis formation led to lower well-being, reduced quality of life and also provoked sever postoperative hypocalcemia («hungry bone» syndrome).

  • Open Access

    The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism

    by Liubov G. Yanevskaya, Karina A. Pogosian, Alisa N. Semenova, Roman A. Chernikov, Dmitrii M. Buzanakov, Olga D. Belyaeva, Elena N. Grineva, Tatiana L. Karonova, Яневская Любовь Геннадьевна

    Background. The relationships between renin-angiotensin-aldosterone system (RAAS) and elevated parathyroid hormone levels in primary hyperparathyroidism (PHPT) is being actively discussed. But the way how parathyroid hormone interacts with renin and aldosterone currently is not clear. Materials and methods. Forty patients aged 18 to 70 years with a confirmed diagnosis of PHPT were involved in the study. All patients were tested for the main parameters of phosphorus-calcium metabolism and the RAAS parameters (plasma renin, plasma aldosterone) before and 2 weeks after parathyroidectomy. Results. Sixty percent of patients had any cardiovascular disease (CVD) and hypertension was the most common. Patients CVD in comparison with patients without CVD were older (61 and 41 years, respectively; p0.001), had a higher body mass index (28.9 and 21.9 kg/m2, respectively; p0.001) and had a lower aldosterone-to-renin ratio ARR (1.78 and 5.42, respectively; p=0.030). Patients with hypertension were older than patients with normal blood pressure (63 and 41 years, respectively; p0.001), had a higher body mass index (28.1 and 23.5 kg/m2, respectively; p=0.005), a lower ARR (1.46 and 5.82, respectively; p=0.001), as well higher levels of plasma renin (109.2 and 20.3 pg/ml, respectively; p=0.007) and serum total calcium (2.84 and 2.71 mmol/l, respectively; p=0.041). Correlation analysis showed that in patients with PHPT and CVD, the concentration of aldosterone is associated with the level of 24-hour urinary calcium (r=0.829, p=0.042), and in patients with symptomatic PHPT and CVD, the level of aldosterone correlated with the level of ionized calcium (r=-0.812, p=0.05). We found no significant differences between the levels of renin, aldosterone and ARR before and 2 weeks after parathyroidectomy. However, in the postoperative period, there were no differences in the levels of renin and ARR among patients with hypertension and without hypertension. Conclusion. In our study we found that the levels of plasma renin and serum total calcium were higher in patients with PHPT and hypertension compared to patients with normal blood pressure. Also, we found the associations between plasma aldosterone and levels of ionized calcium and 24-hour urinary calcium. But the relationships between RAAS parameters and parameters of phosphorus-calcium metabolism need further investigations.